Workflow
Xinguang Pharma(300519)
icon
Search documents
新光药业(300519)8月12日主力资金净流出1636.72万元
Sou Hu Cai Jing· 2025-08-12 10:35
金融界消息 截至2025年8月12日收盘,新光药业(300519)报收于17.32元,下跌1.81%,换手率 6.11%,成交量6.97万手,成交金额1.21亿元。 资金流向方面,今日主力资金净流出1636.72万元,占比成交额13.5%。其中,超大单净流出289.51万 元、占成交额2.39%,大单净流出1347.22万元、占成交额11.12%,中单净流出流出472.31万元、占成交 额3.9%,小单净流入2109.04万元、占成交额17.4%。 新光药业最新一期业绩显示,截至2025一季报,公司营业总收入9325.01万元、同比减少7.26%,归属净 利润2454.18万元,同比增长7.50%,扣非净利润2336.65万元,同比增长9.49%,流动比率13.066、速动 比率12.251、资产负债率7.46%。 天眼查商业履历信息显示,浙江新光药业股份有限公司,成立于1998年,位于绍兴市,是一家以从事医 药制造业为主的企业。企业注册资本16000万人民币,实缴资本16000万人民币。公司法定代表人为王岳 钧。 通过天眼查大数据分析,浙江新光药业股份有限公司共对外投资了4家企业,参与招投标项目26次,知 ...
A股早评:创业板指高开0.65%,消费电子概念活跃!易德龙、福日电子涨停;两船合并新进展,将于8月13日起双双停牌,中国船舶涨超3%,中国重工涨超2%
Ge Long Hui· 2025-08-05 01:51
Market Overview - The A-share market opened with the Shanghai Composite Index rising by 0.15%, the Shenzhen Component Index increasing by 0.34%, and the ChiNext Index up by 0.65% [1] Sector Performance - The consumer electronics sector showed initial activity, with stocks such as Yidelong (603380) and Furi Electronics (600203) hitting the daily limit [1] - The "merger of two shipbuilding companies" has new developments, with both China Shipbuilding (600150) and China Heavy Industry (601989) seeing increases of over 3% and 2% respectively [1] - Some film and theater stocks experienced a pullback, with Happiness Blue Ocean (300528) declining by over 3% [1] - The traditional Chinese medicine sector saw a decline, with Qizheng Cang Medicine (002287) and Xinguang Pharmaceutical (300519) dropping by over 5% [1]
新光药业股价上涨1.26% 盘中振幅达10.76%
Jin Rong Jie· 2025-08-04 17:16
Group 1 - The latest stock price of Xinguang Pharmaceutical is 20.05 yuan, an increase of 0.25 yuan from the previous trading day [1] - The stock opened at 18.86 yuan, reached a high of 20.28 yuan, and a low of 18.15 yuan, with an overall fluctuation of 10.76% throughout the day [1] - The trading volume was 260,458 hands, with a total transaction amount of 491 million yuan [1] Group 2 - Xinguang Pharmaceutical operates in the pharmaceutical manufacturing industry, specifically in the traditional Chinese medicine production sector [1] - The company is primarily engaged in the research, development, production, and sales of traditional Chinese medicine, chemical drug formulations, and raw materials [1] - Its product range covers multiple therapeutic areas, including cardiovascular, digestive, and respiratory systems [1] Group 3 - On August 4, the stock experienced a rapid rebound during the morning trading session, with a rise of over 2% within 5 minutes [1] - As of 9:37 AM, the stock price was reported at 18.95 yuan, with a transaction amount reaching 105 million yuan [1] - In terms of capital flow, there was a net outflow of 4.5732 million yuan from the main funds on that day, accounting for 0.2% of the circulating market value [1] - Over the past five trading days, the cumulative net inflow of main funds was 22.5547 million yuan, representing 0.99% of the circulating market value [1]
A股中药股逆势上涨,生物谷涨25%,维康药业20CM涨停,新光药业涨13%,大唐药业涨11%,太龙药业、贵州百灵涨停
Ge Long Hui· 2025-08-01 06:05
(责任编辑:宋政 HN002) 格隆汇8月1日|A股市场中药股逆势上涨,其中,生物谷涨近25%,维康药业20CM涨停,新光药业 (300519)涨13%,大唐药业涨近11%,天目药业(600671)、新天药业(002873)、太龙药业(600222)、奇正 藏药(002287)、贵州百灵(002424)10CM涨停,众生药业(002317)涨超8%,亚宝药业(600351)、沃华医药 (002107)涨超6%。 | 代码 | 名称 | 涨幅% ↓ | 总市值 | 年初至今涨幅%。 | | --- | --- | --- | --- | --- | | 833266 | 生物谷 | 24.91 | 17.60亿 | 51.12 | | 300878 | 维康药业 | 20.00 | 37.10亿 | 71.51 | | 300519 | 新光药业 | 13.04 | 31.76亿 | 52.71 | | 836433 | 大唐药业 | 10.76 | 22.14亿 | 42.65 | | 600671 | 天目药业 | 10.03 | 18.71亿 | 74.94 | | 002873 | 新天药业 | 10. ...
A股中药股逆势上涨,太龙药业、贵州百灵等多股涨停
Ge Long Hui A P P· 2025-08-01 05:51
MACD金叉信号形成,这些股涨势不错! 格隆汇8月1日|A股市场中药股逆势上涨,其中,生物谷(维权)涨近25%,维康药业(维权)20CM 涨停,新光药业涨13%,大唐药业涨近11%,天目药业、新天药业、太龙药业、奇正藏药、贵州百灵 (维权)10CM涨停,众生药业涨超8%,亚宝药业、沃华医药(维权)涨超6%。 | 代码 | 名称 | 涨幅% ↓ | 总市值 | 年初至今涨幅% | | --- | --- | --- | --- | --- | | 833266 | 生物谷 | 24.91 | 17.60亿 | 51.12 | | 300878 | 维康药业 | 20.00 | 37.10亿 | 71.51 | | 300519 | 新光药业 | 13.04 | 31.76 乙 | 52.71 | | 836433 | 大唐药业 | 10.76 | 22.14亿 | 42.65 | | 600671 | 天目药业 | 10.03 | 18.71亿 | 74.94 | | 002873 | 新天药业 | 10.03 | 29.19亿 | 27.68 | | 600222 | 太龙药业 | 10.00 | 39.14 ...
中药板块逆势拉升 天目药业等多股涨停
Mei Ri Jing Ji Xin Wen· 2025-08-01 05:50
(文章来源:每日经济新闻) 每经AI快讯,8月1日,午后中药板块持续逆势拉升,天目药业、华森制药涨停,生物谷一度触及30%涨 停,新光药业、大唐药业涨超10%,亚宝药业、沃华医药、陇神戎发、粤万年青等跟涨。 ...
A股中药板块持续逆势拉升,天目药业、华森制药涨停,生物谷一度触及30cm涨停,新光药业、大唐药业涨超10%,亚宝药业、沃华医药、陇神戎发、粤万年青等跟涨。
news flash· 2025-08-01 05:44
Group 1 - The A-share traditional Chinese medicine sector is experiencing a significant upward trend, with companies like Tianmu Pharmaceutical and Huasen Pharmaceutical hitting the daily limit increase [1] - Biotech Valley reached a peak of 30cm limit increase, indicating strong market interest and investor confidence [1] - Other companies such as New Light Pharmaceutical and Datang Pharmaceutical saw increases of over 10%, reflecting a broader positive movement in the sector [1] Group 2 - Additional companies including Yabao Pharmaceutical, Wohua Pharmaceutical, Longshen Rongfa, and Guangdong Wannianqing also showed gains, contributing to the overall bullish sentiment in the traditional Chinese medicine market [1]
A股辅助生殖板块持续走强,福元医药盘中创历史新高,共同药业、汉商集团、利德曼涨停,安科生物涨超15%,广生堂涨超10%,新光药业、达嘉维康、贝因美、星昊医药、贝瑞基因跟涨。
news flash· 2025-07-31 02:25
Core Viewpoint - The A-share assisted reproductive sector is experiencing significant growth, with multiple companies reaching new highs and notable stock price increases [1] Company Performance - Fuyuan Pharmaceutical reached an all-time high during trading [1] - Gongtong Pharmaceutical, Hanshang Group, and Lide Man all hit the daily limit up [1] - Anke Bio increased by over 15% [1] - Guangshengtang rose by over 10% [1] - Other companies such as Xinguang Pharmaceutical, Dajia Weikang, BeiYinMei, Xinghao Pharmaceutical, and Beirui Gene also saw price increases [1]
新光药业(300519) - 关于注销部分募集资金专户的公告
2025-05-30 08:16
证券代码:300519 证券简称:新光药业 公告编号:2025-018 浙江新光药业股份有限公司 关于注销部分募集资金专户的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 浙江新光药业股份有限公司(以下简称"公司")于 2025 年 4 月 17 日召 开第五届董事会第三次会议及第五届监事会第三次会议,审议通过《关于首次公 开发行股票的部分募集资金投资项目结项并将节余募集资金永久补充流动资金及 注销部分募集资金专用账户的议案》,并于 2025 年 5 月 13 日召开的 2024 年度 股东大会审议通过了上述议案,同意公司将由公司全资子公司浙江新光医药科技 有限公司(以下简称"新光医药科技")建设的"现代中药研发中心建设项目" 进行结项,将节余募集资金永久补充流动资金,并对相关募集资金专户进行销户 处理。具体详见公司于 2025 年 4 月 21 日在巨潮资讯网(www.cninfo.com.cn) 披露的《关于首次公开发行股票的部分募集资金投资项目结项并将节余募集资金 永久补充流动资金及注销部分募集资金专用账户的公告》(公告编号:2025- 010)。 ...
晚间公告丨5月23日这些公告有看头
第一财经· 2025-05-23 15:00
Group 1 - Ningde Times participated in the completion of the Zeyuan Fund, with a total scale of 10.128 billion yuan, increasing by 50.42% from the previous announcement [3] - Zhongjin Gold's controlling shareholder plans to inject four companies into the company to resolve competition issues, including acquiring stakes in Inner Mongolia Jintao and others [4][5] - Keli Yuan plans to invest an additional 500 million yuan in a storage industry fund, increasing its total investment to 700 million yuan [6] Group 2 - China Shenhua intends to acquire 7.43% of the National Energy Group Financial Company for 2.929 billion yuan, which is expected to increase its net profit by 97 million yuan [7] - Weir Shares plans to issue H-shares and list on the Hong Kong Stock Exchange [8] - Hualan Shares is establishing a joint venture for Tibetan medicinal baths and plaster products, with a registered capital of 7 million yuan [15] Group 3 - Yunnan Copper plans to acquire 40% of Liangshan Mining through a share issuance, with the stock resuming trading on May 26 [10] - Ruishun Technology's subsidiary plans to establish a joint venture in Malaysia to provide automation solutions [11] - ST Quanwei's stock will be subject to additional risk warnings due to ongoing litigation involving a subsidiary [12] Group 4 - Hengfeng Information's controlling shareholder has terminated the agreement to transfer part of the company's shares, with no impact on control [13] - Huadian Technology's subsidiary has not yet commenced substantial construction on a polyurethane new materials project [14] - ST Yinjian will remove the delisting risk warning and some other risk warnings, changing its stock name [38] Group 5 - China Tonghao won approximately 3.789 billion yuan in contracts in the rail transit market from March to April [39] - Intercontinental Oil and Gas plans to invest about 848 million USD in the Iraq South Basra project [40][41] - Jiaying Pharmaceutical's subsidiary signed a contract for the development of a traditional Chinese medicine innovation project [42] Group 6 - Ruidong Intelligent signed a strategic cooperation agreement with Shunde Vocational and Technical College to enhance collaboration in technology [43] - Jiaojian Co. won a bid for a drainage project worth 225 million yuan [44] - Hengshun Vinegar's controlling shareholder plans to increase its stake in the company by 50 to 100 million yuan [45]